Stefan Fröhling

32.2k total citations · 6 hit papers
210 papers, 11.2k citations indexed

About

Stefan Fröhling is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Stefan Fröhling has authored 210 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 66 papers in Hematology and 64 papers in Oncology. Recurrent topics in Stefan Fröhling's work include Acute Myeloid Leukemia Research (59 papers), Cancer Genomics and Diagnostics (53 papers) and Sarcoma Diagnosis and Treatment (25 papers). Stefan Fröhling is often cited by papers focused on Acute Myeloid Leukemia Research (59 papers), Cancer Genomics and Diagnostics (53 papers) and Sarcoma Diagnosis and Treatment (25 papers). Stefan Fröhling collaborates with scholars based in Germany, United States and United Kingdom. Stefan Fröhling's co-authors include Hartmut Döhner, Konstanze Döhner, Richard F. Schlenk, Claudia Scholl, Lars Bullinger, Axel Benner, Andrea Corbacioglu, D. Gary Gilliland, Marianne Habdank and Jonathan R. Pollack and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Stefan Fröhling

203 papers receiving 11.0k citations

Hit Papers

Mutations and Treatment Outcome in Cytogenetically Normal... 2002 2026 2010 2018 2008 2004 2002 2005 2011 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
    2008 1.1k citations Richard F. Schlenk, Stefan Fröhling et al. profile →
  2. Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia
    2004 703 citations Lars Bullinger, Stefan Fröhling et al. profile →
  3. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm
    2002 660 citations Stefan Fröhling, Richard F. Schlenk et al. profile →
  4. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations
    2005 603 citations Richard F. Schlenk, Claudia Scholl et al. profile →
  5. Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction
    2011 451 citations Stefan Fröhling et al. profile →
  6. Accurate and efficient detection of gene fusions from RNA sequencing data
    2021 208 citations Sebastian Uhrig, Martina Fröhlich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Fröhling Germany 51 5.6k 5.5k 2.2k 2.0k 1.9k 210 11.2k
Alexander Kohlmann Germany 44 3.8k 0.7× 3.6k 0.7× 1.7k 0.8× 1.8k 0.9× 1.4k 0.7× 181 7.5k
Robert B. Gerbing United States 51 4.6k 0.8× 3.9k 0.7× 2.1k 1.0× 1.3k 0.7× 2.1k 1.1× 239 11.0k
Richard F. Schlenk Germany 52 6.3k 1.1× 9.9k 1.8× 1.8k 0.8× 3.7k 1.8× 1.8k 0.9× 245 13.4k
Martin Carroll United States 49 6.8k 1.2× 4.7k 0.8× 2.6k 1.2× 2.1k 1.1× 2.3k 1.2× 200 11.7k
Uwe Platzbecker Germany 54 3.6k 0.6× 8.8k 1.6× 1.7k 0.8× 4.1k 2.0× 692 0.4× 543 11.3k
Omar Abdel‐Wahab United States 68 10.9k 2.0× 7.4k 1.3× 2.2k 1.0× 5.3k 2.6× 3.7k 1.9× 306 18.6k
David Grimwade United Kingdom 50 8.4k 1.5× 12.7k 2.3× 1.8k 0.8× 3.0k 1.5× 1.4k 0.7× 152 15.6k
Elisabeth Paietta United States 61 4.7k 0.8× 7.8k 1.4× 3.0k 1.4× 2.6k 1.3× 773 0.4× 278 12.9k
Matthew J. Walter United States 29 4.5k 0.8× 2.6k 0.5× 1.6k 0.7× 1.1k 0.5× 2.3k 1.2× 107 7.6k
Mark J. Levis United States 63 6.8k 1.2× 11.3k 2.1× 2.0k 0.9× 4.3k 2.1× 816 0.4× 323 14.5k

Countries citing papers authored by Stefan Fröhling

Since Specialization
Citations

This map shows the geographic impact of Stefan Fröhling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Fröhling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Fröhling more than expected).

Fields of papers citing papers by Stefan Fröhling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Fröhling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Fröhling. The network helps show where Stefan Fröhling may publish in the future.

Co-authorship network of co-authors of Stefan Fröhling

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Fröhling. A scholar is included among the top collaborators of Stefan Fröhling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Fröhling. Stefan Fröhling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edsjö, Anders, Birgit Geoerger, Frédérique Nowak, et al.. (2023). Precision cancer medicine: Concepts, current practice, and future developments. Journal of Internal Medicine. 294(4). 455–481. 31 indexed citations
2.
Christopoulos, Petros, Richard F. Schlenk, Daniel Kazdal, et al.. (2023). Real‐world data for precision cancer medicine—A European perspective. Genes Chromosomes and Cancer. 62(9). 557–563. 9 indexed citations
3.
Morfouace, Marie, Peter Horak, Simon Kreutzfeldt, et al.. (2022). Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study. European Journal of Cancer. 178. 216–226. 7 indexed citations
4.
Rempel, Eugen, Klaus Kluck, Susanne Beck, et al.. (2022). Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD). npj Precision Oncology. 6(1). 36–36. 49 indexed citations
5.
Simon, Malte, Sadaf S. Mughal, Peter Horak, et al.. (2021). Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations. Journal of Translational Medicine. 19(1). 204–204. 3 indexed citations
6.
Maurus, Katja, Corinna Kosnopfel, Hermann Kneitz, et al.. (2021). Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway. British Journal of Dermatology. 186(3). 553–563. 2 indexed citations
7.
Koelsche, Christian, Jamal Benhamida, F. Kommoss, et al.. (2021). Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature. Modern Pathology. 34(12). 2122–2129. 24 indexed citations
8.
Seidensaal, Katharina, Semi Harrabi, Fabian Weykamp, et al.. (2020). Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution. Radiation Oncology. 15(1). 143–143. 10 indexed citations
9.
Kommoss, F., F. Kommoss, Kenneth Tou En Chang, et al.. (2020). Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications. The Journal of Pathology Clinical Research. 6(3). 178–184. 36 indexed citations
10.
Loosen, Sven H., Nadine T. Gaisa, Maximilian Schmeding, et al.. (2020). Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma. Case Reports in Gastroenterology. 14(3). 658–667. 3 indexed citations
11.
Jensen, Patrizia, Michela Carlet, Richard F. Schlenk, et al.. (2020). Requirement for LIM kinases in acute myeloid leukemia. Leukemia. 34(12). 3173–3185. 11 indexed citations
12.
Berger, Anne, Sadaf S. Mughal, Michael Allgäuer, et al.. (2020). Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare disease. Pancreatology. 20(3). 425–432. 17 indexed citations
13.
Feuerbach, Lars, Lina Sieverling, Katharina I. Deeg, et al.. (2019). TelomereHunter – in silico estimation of telomere content and composition from cancer genomes. BMC Bioinformatics. 20(1). 272–272. 45 indexed citations
14.
Korzeniewski, Nina, Samuel Peña‐Llopis, Claudia Scholl, et al.. (2019). Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability. Oncogenesis. 8(1). 4–4. 11 indexed citations
15.
Buchhalter, Ivo, Eugen Rempel, Volker Endris, et al.. (2018). Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis. International Journal of Cancer. 144(4). 848–858. 117 indexed citations
16.
Trautmann, Marcel, Konrad Steinestel, Inga Grünewald, et al.. (2017). FUS–DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma. Clinical Cancer Research. 23(20). 6227–6238. 38 indexed citations
17.
Budczies, Jan, Michael Bockmayr, Frederick Klauschen, et al.. (2017). Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan‐cancer survey with implications for the use of immune checkpoint inhibitors. Genes Chromosomes and Cancer. 56(8). 651–659. 32 indexed citations
18.
Czink, Elena, Christoph Heining, Theresia Weber, et al.. (2016). Dauerhafte Remission unter dualer HER2-Blockade mit Trastuzumab und Pertuzumab bei metastasiertem Gallenblasenkarzinom. Zeitschrift für Gastroenterologie. 54(5). 426–430. 15 indexed citations
19.
Azoitei, Ninel, Kristina Diepold, Cornelia Brunner, et al.. (2014). HSP90 Supports Tumor Growth and Angiogenesis through PRKD2 Protein Stabilization. Cancer Research. 74(23). 7125–7136. 51 indexed citations
20.
Kharas, Michael G., Christopher J. Lengner, Fátima Al‐Shahrour, et al.. (2010). Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Kohlmann Breakdown of academic impact, for papers by Robert B. Gerbing Breakdown of academic impact, for papers by Richard F. Schlenk Breakdown of academic impact, for papers by Martin Carroll Breakdown of academic impact, for papers by Uwe Platzbecker Breakdown of academic impact, for papers by Omar Abdel‐Wahab Breakdown of academic impact, for papers by David Grimwade Breakdown of academic impact, for papers by Elisabeth Paietta Breakdown of academic impact, for papers by Matthew J. Walter Breakdown of academic impact, for papers by Mark J. Levis
Rankless by CCL
2026